Therapeutic targets of hypercholesterolemia: HMGCR and LDLR.

Diabetes Metab Syndr Obes

Department of Endocrinology, Shandong Rongjun General Hospital, Jinan 250013, People's Republic of China.

Published: August 2019

Cholesterol homeostasis is critical and necessary for the body's functions. Hypercholesterolemia can lead to significant clinical problems, such as cardiovascular disease (CVD). 3-Hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) and low-density lipoprotein cholesterol receptor (LDLR) are major points of control in cholesterol homeostasis. We summarize the regulatory mechanisms of HMGCR and LDLR, which may provide insight for new drug design and development.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709517PMC
http://dx.doi.org/10.2147/DMSO.S219013DOI Listing

Publication Analysis

Top Keywords

hmgcr ldlr
8
cholesterol homeostasis
8
therapeutic targets
4
targets hypercholesterolemia
4
hypercholesterolemia hmgcr
4
ldlr cholesterol
4
homeostasis critical
4
critical body's
4
body's functions
4
functions hypercholesterolemia
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!